Download presentation
Presentation is loading. Please wait.
1
Volume 92, Issue 2, Pages 461-469 (August 2017)
Recurrent glomerulonephritis after kidney transplantation: risk factors and allograft outcomes Penelope J. Allen, Steve J. Chadban, Jonathan C. Craig, Wai H. Lim, Richard D.M. Allen, Philip A. Clayton, Armando Teixeira-Pinto, Germaine Wong Kidney International Volume 92, Issue 2, Pages (August 2017) DOI: /j.kint Copyright © Terms and Conditions
2
Figure 1 Cohort profile. ESKD, end-stage kidney disease; FSGS, focal segmental glomerulosclerosis; GN, glomerulonephritis; MPGN, membranoproliferative glomerulonephritis. Kidney International , DOI: ( /j.kint ) Copyright © Terms and Conditions
3
Figure 2 Kaplan–Meier estimates of disease recurrence, stratified by glomerulonephritis (GN) types: focal segmental glomerulosclerosis (FSGS), IgA nephropathy, membranoproliferative glomerulonephritis (MPGN), and membranous GN. Kidney International , DOI: ( /j.kint ) Copyright © Terms and Conditions
4
Figure 3 Adjusted hazard ratios for disease recurrence according to age in recipients with recurrent glomerulonephritis as the primary cause of end-stage kidney disease. CI, confidence interval. Kidney International , DOI: ( /j.kint ) Copyright © Terms and Conditions
5
Figure 4 Kaplan–Meier estimates of overall and death-censored allograft loss in those with and without recurrent glomerulonephritis. Kidney International , DOI: ( /j.kint ) Copyright © Terms and Conditions
6
Figure 5 Causes of allograft loss in recipients with recurrent glomerulonephritis (GN). FSGS, focal segmental glomerulosclerosis; MPGN, membranoproliferative glomerulonephritis. Kidney International , DOI: ( /j.kint ) Copyright © Terms and Conditions
7
Figure 6 Allograft survival after recurrence, stratified by glomerulonephritis (GN) type: focal segmental glomerulosclerosis (FSGS), IgA nephropathy, membranoproliferative glomerulonephritis (MPGN), and membranous GN. Kidney International , DOI: ( /j.kint ) Copyright © Terms and Conditions
Similar presentations
© 2025 SlidePlayer.com. Inc.
All rights reserved.